Cargando…

A novel SMARCAL1 mutation associated with a mild phenotype of Schimke immuno-osseous dysplasia (SIOD)

BACKGROUND: Schimke immuno-osseous dysplasia (SIOD, OMIM #242900) is an autosomal-recessive pleiotropic disorder characterized by spondyloepiphyseal dysplasia, renal dysfunction and T-cell immunodeficiency. SIOD is caused by mutations in the gene SMARCAL1. CASE PRESENTATION: We report the clinical a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santangelo, Luisa, Gigante, Maddalena, Netti, Giuseppe Stefano, Diella, Sterpeta, Puteo, Flora, Carbone, Vincenza, Grandaliano, Giuseppe, Giordano, Mario, Gesualdo, Loreto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973878/ https://www.ncbi.nlm.nih.gov/pubmed/24589093 http://dx.doi.org/10.1186/1471-2369-15-41

Ejemplares similares

T-cell receptor signaling in Schimke immuno-osseous dysplasia is SMARCAL1-independent
por: Marin, Ana V., et al.
Publicado: (2022)

Podocytic infolding in Schimke immuno-osseous dysplasia with novel SMARCAL1 mutations: a case report
por: Xiong, Shiqiu, et al.
Publicado: (2020)

Schimke Immuno-osseous Dysplasia: A Case Report
por: Babaei, Amir Hossein, et al.
Publicado: (2019)

Disseminated cutaneous papillomas in Schimke immuno-osseous dysplasia
por: Lücke, Thomas, et al.
Publicado: (2008)

Early Onset Cerebral Infarction in Schimke Immuno-Osseous Dysplasia
por: HOSSEIN BABAEI, Amir, et al.
Publicado: (2018)

Schimke immuno-osseous dysplasia. A case report in Colombia
por: Orozco, Rafael Adrián Pacheco, et al.
Publicado: (2023)

Rituximab resistant evans syndrome and autoimmunity in Schimke immuno-osseous dysplasia
por: Zieg, Jakub, et al.
Publicado: (2011)

Non-Hodgkin Lymphoma in a Child with Schimke Immuno-Osseous Dysplasia
por: Basiratnia, Mitra, et al.
Publicado: (2011)

Branchio-Oto-Renal Syndrome (BOR) associated with focal glomerulosclerosis in a patient with a novel EYA1 splice site mutation
por: Gigante, Maddalena, et al.
Publicado: (2013)

Low renal but high extrarenal phenotype variability in Schimke immuno-osseous dysplasia
por: Lipska-Ziętkiewicz, Beata S., et al.
Publicado: (2017)

A novel compound heterozygous mutation of the SMARCAL1 gene leading to mild Schimke immune-osseous dysplasia: a case report
por: Liu, Shuaimei, et al.
Publicado: (2017)

A Case of Schimke Immunoosseous Dysplasia Caused by Large Deletion of SMARCAL1 Gene
por: Malhotra, Rakhi, et al.
Publicado: (2021)

Reduced elastogenesis: a clue to the arteriosclerosis and emphysematous changes in Schimke immuno-osseous dysplasia?
por: Morimoto, Marie, et al.
Publicado: (2012)

A novel compound heterozygous variant in SMARCAL1 leading to mild Schimke immune-osseous dysplasia identified using whole-exome sequencing
por: Wang, Li, et al.
Publicado: (2021)

Increased Wnt and Notch signaling: a clue to the renal disease in Schimke immuno-osseous dysplasia?
por: Morimoto, Marie, et al.
Publicado: (2016)

Whole Exome Sequencing Identified a Novel Biallelic SMARCAL1 Mutation in the Extremely Rare Disease SIOD
por: Jin, Jing, et al.
Publicado: (2019)

Expanding Phenotype of Schimke Immuno-Osseous Dysplasia: Congenital Anomalies of the Kidneys and of the Urinary Tract and Alteration of NK Cells
por: Bertulli, Cristina, et al.
Publicado: (2020)

Moyamoya Syndrome in Schimke Immune-Osseous Dysplasia: A Rare Association
por: Nayak, Manoj, et al.
Publicado: (2022)

Schimke immunoosseous dysplasia: defining skeletal features
por: Hunter, Kshamta B., et al.
Publicado: (2009)

Soluble Serum αKlotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma
por: Gigante, Margherita, et al.
Publicado: (2015)

Local synthesis of interferon-alpha in lupus nephritis is associated with type I interferons signature and LMP7 induction in renal tubular epithelial cells
por: Castellano, Giuseppe, et al.
Publicado: (2015)

Identification and Characterization of SMARCAL1 Protein Complexes
por: Bétous, Rémy, et al.
Publicado: (2013)

On the Interaction Between SMARCAL1 and BRG1
por: Bisht, Deepa, et al.
Publicado: (2022)

Emerging Biomarkers in Renal Damage
por: Ditonno, Pasquale, et al.
Publicado: (2014)

Low C3 Serum Levels Predict Severe Forms of STEC-HUS With Neurologic Involvement
por: Netti, Giuseppe Stefano, et al.
Publicado: (2020)

CD40 Cross-Linking Induces Migration of Renal Tumor Cell through Nuclear Factor of Activated T Cells (NFAT) Activation
por: Pontrelli, Paola, et al.
Publicado: (2021)

Rothmund-Thomson syndrome: Immuno-osseous challenges
por: Meyts, I, et al.
Publicado: (2011)

The Role of Natural Killer Cells in the Immune Response in Kidney Transplantation
por: Pontrelli, Paola, et al.
Publicado: (2020)

Coagulation and Fibrinolysis in Kidney Graft Rejection
por: Stallone, Giovanni, et al.
Publicado: (2020)

Endothelial dysfunction and renal fibrosis in endotoxemia-induced oliguric kidney injury: possible role of LPS-binding protein
por: Castellano, Giuseppe, et al.
Publicado: (2014)

Semaphorin 3F expression is reduced in pregnancy complicated by preeclampsia. An observational clinical study
por: Stallone, Giovanni, et al.
Publicado: (2017)

SMARCAL1 Resolves Replication Stress at ALT Telomeres
por: Cox, Kelli E., et al.
Publicado: (2016)

Altered Phosphorylation of Cytoskeleton Proteins in Peripheral Blood Mononuclear Cells Characterizes Chronic Antibody-Mediated Rejection in Kidney Transplantation
por: Rocchetti, Maria Teresa, et al.
Publicado: (2020)

The Ambivalent Role of miRNAs in Carcinogenesis: Involvement in Renal Cell Carcinoma and Their Clinical Applications
por: Spadaccino, Federica, et al.
Publicado: (2021)

Serum Levels of BAFF and APRIL Predict Clinical Response in Anti-PLA2R-Positive Primary Membranous Nephropathy
por: Netti, Giuseppe Stefano, et al.
Publicado: (2019)

mTOR inhibitors improve both humoral and cellular response to SARS-CoV-2 messenger RNA BNT16b2 vaccine in kidney transplant recipients
por: Netti, Giuseppe S., et al.
Publicado: (2022)

Can SGLT2 inhibitors answer unmet therapeutic needs in chronic kidney disease?
por: De Nicola, Luca, et al.
Publicado: (2022)

Modulation of complement activation by pentraxin-3 in prostate cancer
por: Stallone, Giovanni, et al.
Publicado: (2020)

Treatment with rituximab in idiopathic membranous nephropathy
por: Fiorentino, Marco, et al.
Publicado: (2016)

Recurrence of immunoglobulin A nephropathy after kidney transplantation: a narrative review of the incidence, risk factors, pathophysiology and management of immunosuppressive therapy
por: Infante, Barbara, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d25qbe932hn7ba08lbjfu2lomf